Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yes, tempted myself. Great offer. Best price per bottle I've ever seen.
CEO on X - 12/13/23
Tollovid target site for 3CL protease inhibition is the site nature targets. Pfizer's Paxlovid targets a different site on the protein, which Dr. Arad has previously stated is likely more susceptible to viral mutations rendering it less effective. Paxlovid is based on her earlier research, while Tollovid is based on her latest research. I know I'm using the better product and thankful that Dr. Arad and Todos has made it available to me.
If I'm a fool with his money, then I will own it and accept responsibility for my actions. Unlike many here who blame the CEO or other investors who lead them to their fate. I'm confident if the shoe was on the other foot and they made a fortune in this investment, they would point to only themselves as the savvy investor who had the foresight to invest. Take responsibility for wins, defer blame for losses. That seems to be the way of the world nowadays. Where do you fall in that spectrum?
I've posted when I purchased shares. Some thought I was lying so I posted proof of my buys. I haven't sold any shares. It's called accumulating based on what I believe may unfold with Todos. I might be wrong, so feel free to ignore what I'm doing. Everyone has to decide for themselves, but anyone blaming me for leading them down this path shouldn't be investing if they can't make their own decisions and accept responsibility. My suggestion to those people is to "F*ck Off".
I bought a ton in my Roth because I was putting $50K or more per year in the Roth, and directed a lot of that towards Todos shares. I also bought a lot in my regular IRA and in a fully taxable account. My Todos holdings are split across all three accounts. My suggestion for using a Roth was under the assumption someone was already going to buy Todos shares, so buying in a Roth would eliminate tax on gains and withdrawals... a very nice place to be if the company succeeded. The drawback is you can't uses losses against ordinary income to save on taxes. You can't do that with a regular IRA either.
So what's your point?
I'm not posting to try to get someone to invest so I can unload my shares. I'm seeing this story through to the conclusion. I may or may not choose to buy more shares, depending on my outlook. My risk tolerance is likely different from yours.
If you believe Red and I and a few others are pumping this stock, you're wrong. Head over the the MONI board and you'll see a true pump and dump in action. You're not seeing any of us suggesting where the Todos share price will be at some point. Yes, we are invested because we believe it will be higher. I only have to get to 0.4 cents to break even. I certainly believe this can go higher than that if things continue with the way Long Covid is going. Anyone still invested here who doesn't believe it will go higher should simply exit and move on. There's a positive psychological aspect to closing out of a losing investment and moving on. Learn from the experience and become better with the next investment decision.
Those who suggest several of us here are back office boys working for Todos are delusional and complete morons. You know who I'm speaking of. Look at how they pump on MONI and IBIO boards. I seriously wish some would just put those of us invested here on ignore, but that's not their agenda.
Here's another thought to consider... the company is clearly issuing shares to fund operations. Who is buying those shares? Who would buy shares in this company on that level if they believe the company and their products are toast? That's a topic no one seems to want to address.
I'm not enticing anyone to buy. My money, my outlook, my decision to invest. If you have a different opinion, then don't invest. The board is for discussion of Todos, products, and where we believe things may go. But when you make the claim EVERYONE is down 99.9%, that opens you up to correction.
Everyone is not down 99.9%. Some continued to pick up larger and larger numbers of shares as the price declined, and continue to buy even now. That can have a pretty dramatic impact on cost basis.
Try again. Make another assumption.
Why do you continue to respond to this AssClown? Block him like Red and I have done. Your life will improve dramatically when you remove his insane rants from your life. You also won't have to deal with his vulgar private messages if he's blocked.
And certainly don't invest in any company he invests in, unless you enjoy losing money. One of the most consistently wrong investors I've ever witnessed based on his posting history. Insanely skilled at picking losers.
There is an Israeli product called Enovid that's a nasal spray I purchased last year. It's designed to be carried with you and used when you're around other people, before or after contact. It kills the virus in the nasal passages and can be used to help prevent infection. It uses a patented injector that creates nitrous oxide immediate with each injection, which kills the virus.
I can provide the info if you're interested. When I purchased 3 bottles it was $40/bottle, and each bottle lasts about 2 months with daily use. I used it occasionally while at work, but another family member swears by it and says it cleared up his sinus issues better than anything he's tried before, while also providing protection against Covid infection. I suspect the nitrous oxide cleared up other long-standing infections that had become resistant over time to the drugs he was being prescribed.
I received the Novavax vaccine a few weeks ago and I continue to take Tollovid daily. Vaccines don't ensure 100% protection. People assume only the unvaccinated have contracted Covid, but I've known many people who were infected even though they were vaccinated. Same goes with the annual flu vaccine. Viruses mutate and each vaccine produced provides good protections against some strains and less protections against other strains. Vaccines are always playing catch-up to the viral mutations.
Since the protease inhibition mechanism of Tollovid has so far not been impacted by these mutations, I continue the daily dose as additional protection where the vaccines may fall short. Paxlovid uses a different target site to provide its protease inhibition function, and has already been impacted by the mutations where it is not as effective with current strains as with earlier strains. Plus, you need a prescription to get Paxlovid, and only AFTER you've contracted the virus. With Tollovid the protection is already in your body. Seems like a no-brainer if you can afford it and use discounts and bulk ordering to reduce cost. I'm thankful I am able to afford it long-term.
Dr. Dorit Arad has stated she evaluated over 400,000 substances for 3CL protease inhibition in her decades-long research into SARS and other coronaviruses. She found the best inhibitory properties in Gromwell, and developed the process to extract the specific substances identified. She stated that many plants have developed very effective defenses against coronaviruses since these plants are vulnerable as well as humans. Turning her attention to natural plant defense mechanisms is how she discovered and created Tollovid.
Benefits of Tollovid are not the same as ingesting Gromwell root powder purchased online. That will be hit or miss, and could be dangerous as was proven with author Alisa Valdes, who ended up in the hospital after giving away some of the free Tollovid provided for her case study, and replacing it with Gromwell root purchased from Amazon. She had amazing results while on Tollovid that were well documented in her Twitter posts, but her actions invalidated her study and Todos was unable to use her data.
From the Tollovid website: https://mytollovid.com/pages/product-information
PYRROLIZIDINE ALKALOID (PA) CONTENT
Todos ensures the safety of its Tollovid® product lines by meeting or beating rigorous standards set by the European Union for pyrrolizidine alkaloid (PA) content of < 400 ug/kg. These alkaloids constitute a class of plant toxin associated with disease in humans and animals and are commonly found in certain plant species that are used as food supplements. The US FDA has not yet set required standards for PAs. Capsules from all commercial lots of Tollovid® have been tested by an external credentialed reference lab for the presence of PAs. All samples fell below the lower limit of detection for PA content (<5 ug/kg).
HEAVY METALS
Todos ensures compliance with the most rigorous US standards for food supplements in the United States. All batches of Tollovid® are tested for heavy metal toxins and pass current Good Manufacturing Practices (cGMP) quality controls. The titanium dioxide contained in the gelcap surrounding the Tollovid® ingredients is known to be non-carcinogenic when ingested orally. Material from all commercial lots of Tollovid® have been tested by credentialed third-party reference laboratories selected by our contract manufacturer to test for heavy metal.
Good luck with any testing done on products purchased online. You might try it and not have any short-term adverse effects, but as many studies have shown, the harm comes from build-up of these elements in your body. It is commonly known that mercury concentrates in tuna, and most tuna we consume contains low levels of mercury. The levels aren't adverse for occasionally eating tuna, but eating tuna regularly for extended periods can result in dangerous levels of mercury accumulating in the human body. I know a woman who was hospitalized for mercury poisoning as a result of eating 2 - 3 cans of tuna per day over a period of several months, as part of a weight reduction diet. Untested natural products such as Gromwell root can impact us in the same manner with long-term adverse effects that aren't evident in the short term.
Todos Share Update - 12/8/23
107M shares issued since update on 12/1/23.
https://www.otcmarkets.com/stock/TOMDF/security
Good plan. Smart to have several bottles ready if needed. I wouldn't want to get Covid and have to deal with temporary supply chain issues as we've seen in the past and have weeks go by before product is shipped.
I initially took your approach but after taking the acute dose of 12 capsules/day for 5 days (just in case I had already had Covid and was asymptomatic), I discovered other benefits from the supplement, so I began taking it daily. I always buy during sales or use discount codes to reduce cost per bottle well below the $149 price.
When new Tollovid formulations are available as GC has mentioned several times, I will re-evaluate which one best suits my needs.
I have some more real-world feedback on Tollovid. Two of my family members were recently on a bus tour group visiting several areas, including the Biltmore Estate in Asheville, NC. They returned last week, and reported this week that most from that tour group are now positive for Covid. These two family members haven't been vaccinated since the first round of vaccines became available, but have been taking Tollovid daily for the past year. Neither of them contracted Covid from this trip. We strongly believe Tollovid helped them avoid the virus. I continue to take Tollovid twice daily as recommended, have for several years, and remain virus free.
Gromwell root tincture my ass... Tollovid is as good or better than anything those 9 specialists are doling out. Prevention trumps treating post-infection any day. The only way to prevent Long Covid is to remain Covid-free in the first place.
That's been the going theory for a couple of years now. He can't help himself, has so many pics of GC and keeps posting them for all to see. Can't stop following his every move, every tweet, every word in press releases. Kinda like a woman scorned.
The theory is a certain analyst started to identify as a woman way back in the AMBS days, even before it became mainstream, and turned their affections toward the black CEO, who didn't roll that way. The investment losses were just an unfortunate side show to the real loss of unreciprocated affection.
You're not making any sense. You must have contracted Covid multiple times like JP and it's affecting your ability to think or remember things. GM never invested in AMBS. He did invest in Todos and still owns those shares, as I do. Nothing else in your post makes any sense.
But believe whatever you want. JP can help you with recommendations for 9 specialists for your deteriorating cognitive ability. Don't forget to take your Geritol daily. And your Metamucil for regular bowel movement.
Had GM ever invested in AMBS, he would at least have been man enough to sell and move on by this point, and not spend a decade crying on a public message board about it. And if he believed the CEO was a scammer, he certainly wouldn't have been dumb enough to invest with him again. That decision was YOURS. You can't blame that on the CEO.
Just the facts, Sherlock!
"Looky here"? What, are you stuck in 6th grade?
Great detective work, Sherlock. GM was still a struggling college student during AMBS days with no money to invest. Try again.
I took a small position in BIXT. I might add to that the coming weeks. They make a compelling story, and breakthroughs do happen now and then. I'm keeping expectations realistic and not going to lose my mind if it doesn't pan out. GLTY
NEWS: Novavax's Updated COVID-19 Vaccine Now Authorized in Canada
https://ir.novavax.com/press-releases/2023-12-05-Novavaxs-Updated-COVID-19-Vaccine-Now-Authorized-in-Canada
December 5, 2023
• Novavax's updated protein-based non-mRNA COVID-19 vaccine will be available in Canada for individuals aged 12 and older in the coming days
GAITHERSBURG, Md., Dec. 5, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that Health Canada has granted expanded authorization for Nuvaxovid™ XBB.1.5 Vaccine (Recombinant protein, Adjuvanted) (NVX-CoV2601) for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals aged 12 and older. The Public Health Agency of Canada's National Advisory Committee on Immunization recommended XBB COVID-19 vaccines that target more recent, immune-evasive variants of the virus.1
"Today's expanded authorization will support the Canadian government's strong commitment to provide its citizens with effective options, such as our protein-based non-mRNA vaccine, in the campaign against currently circulating COVID-19 variants," said John C. Jacobs, President and Chief Executive Officer, Novavax. "We look forward to helping to protect Canadians in time for the upcoming holiday season and, pending vaccine batch release, have doses in market for access across the country."
The expanded authorization was based on non-clinical data showing that Novavax's COVID-19 vaccine induced functional immune responses against XBB.1.5, XBB.1.16 and XBB.2.3 variants. Additional non-clinical data demonstrated that Novavax's vaccine induced neutralizing antibody responses to subvariants BA.2.86, EG.5.1, FL.1.5.1 and XBB.1.16.6 as well as CD4+ polyfunctional cellular (T-cell) responses against EG.5.1 and XBB.1.16.6. These data indicate Novavax's vaccine can stimulate both arms of the immune system and may induce a broad response against currently circulating variants.2,3
In clinical trials, the most common adverse reactions associated with Novavax's prototype COVID-19 vaccine (NVX-CoV2373) included headache, nausea or vomiting, muscle pain, joint pain, injection site tenderness, injection site pain, fatigue and malaise.
Novavax's updated COVID-19 vaccine is also authorized in the U.S., the European Union and by the WHO, and is under review in other markets.
I had read the article earlier today. The 100% accuracy in the title is misleading. Reading the full article explains why. Notice that a larger trial is needed and the researchers say they need to improve sensitivity and specificity, and deal with the shortcomings of the data produced. Why are improvements needed if it's already at 100%?
While I applaud them for their approach and what is hopefully great news for Alzheimers diagnosis, they have more work to do, just like Todos with LymPro. That horse is still in the race for anyone who reads and comprehends the entire article and doesn't try to present a skewed version.
That's a pretty long list. I believe the WB might have experienced these specific ones, as determined from postings made here (before I placed WB on IGNORE).
- agitation
- irritability
- mental depression
- mood changes
- trouble thinking, speaking, or walking
- darkening of the skin - helps with the infatuation with a certain black CEO
- facial hair growth in females
- loss of sexual desire or ability
- menstrual irregularities
Yes, getting dosed up with dexamethasone explains a lot. Thanks for sharing.
Be sure to let me know when MONI actually generates any revenue or has a deal that finalizes and is reported as such in the filings. You know what those are, right? Maybe you don't since MONI only uses social media to report things.
Go ahead, reply to my post. You know you want to and can't control the urge to get the last word.
A novel, huh? You must not do much reading. 3 sentences and a link. Not even a short-story.
I am familiar with Jonathan D. Leinwand and the post I referenced. It took 2 minutes to dig it up again with Google, and another 2 minutes to post the link to the MONI board along with my post.
OK, you got me. I spent 4 minutes total on the post. Still not hours and hours. So how do you defend the content of my post, where this guy with such a documented shady background is associated with MONI? You can't, except for attacking the poster.
If you really think it took me longer than 4 minutes to research and write that post, your perception of reality is way off.
Clearly you're not referring to me, since my previous post was 12/11/22. Yeah, that's a lot of hours spent here... 2 minutes posting over the last year. LMAO.
No wonder you are easily misled by this scam if your DD is no better than that.
I owned this turd a while back, and glad to have sold at 5.4 cents for a small loss considering how it's tanked since then.
Our next question comes from the line of John Petrosino with JWP Incorporated. Please proceed with your question.
Good afternoon, gentlemen. I want to thank you very much for taking the time out to have this conference call. .... I also wanted to congratulate Amarantus on the outstanding milestone achievements that they have accomplished in 2013. Obviously 2013 was a very challenging year for anybody involved with the .... Things are moving in the right direction very nicely, both on the diagnostic side, as well as the therapeutic side. Congratulations to the new additions, Dr. Lowe being one, Dr. Bier being another with respect to the Board of Directors and the Board of Advisors. Dr. Simon, as well, congratulations to you.
All that said and done, my question was pretty much answered by those who were opposed by both Joseph Napotano, as well as another individual, ... All that said, a couple of things are in the back of my mind. Is there a timeframe, Gerald, that we are looking at with respect to an announcement of the second orphan indication? Is there a min/max of a time period you are looking at here on that second orphan indication?
Okay, thank you very much for that. The second question I have is with regard to the Janssen key freelancing in San Francisco. Congratulations on the move, by the way. It appears as though that is a premier location with a number of contacts and resources for Amarantus, and I’m sure that Amarantus is thrilled to be there. Can you expand upon some of the resources that are available to you there? For example, I see that Johnson & Johnson is a key backer of the facilities there. I also had noticed that J&J, the holding company, being a subsidiary of Johnson & Johnson, co-located there at the California Innovation Center. Are there any particular resources that Amarantus would be focusing on as you prepare to move to the new facilities that are at Janssen in San Francisco?
Great. Congratulations once again, and good luck to all of you gentlemen. Thank you very much for your time and efforts.
Limited vocabulary? Or falling hook, line, and sinker for a high-risk penny stock (with great potential but no revenue) and sinking every dollar he could scrape up in this risky investment? Which is it?
Congratulations... congratulations... congratulations... congratulations... and once again, congratulations!!
Has this analyst ever picked a winning stock?
Interesting info on Jonathan D. Leinwand in the post below. Pretty much paints the picture that MONI is a scam if he's involved.
Scroll down to the From my Notes: section for a long history of Leinwand's involvement with scam companies.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142831370
I expect we'll get news from Todos this week. 🤭
I added a few more shares this week.
Todos Share Update - 11/1/23
75M shares issued since update on 11/17/23.
https://www.otcmarkets.com/stock/TOMDF/security
What happened to the other moderator? The one who invested here at $125 and was continually recommending BUY! BUY! BUY! ???
I can understand how one's heart just isn't in it anymore, after losing that much MONI. Probably had crow instead of turkey over Thanksgiving.
Bought more Todos shares today. 😎
Take a look at what's happening with AMBS share price the last 2 days. Almost like someone knows something. 👍️
I caught that statement by Dr. Arad as well, and looking forward to more clarification on that front.
New video on 3CL Pharma Investment Opportunity
Enjoy!